ONWARD Announces Completion of Enrollment in the Up-LIFT Pivotal Trial of ARC Therapy for Spinal Cord Injury

Enrollment was completed in less than 12 months despite COVID-related challenges, demonstrating strong interest in the therapy THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING

Related Keywords

Germany ,Australia ,Japan ,United States ,Netherlands ,United Kingdom ,Massachusetts ,Boston ,Canada ,Switzerland ,France ,Kostenloser Wertpapierhandel ,Chet Moritz ,Department Of Defense Do ,Cord Injury Research At Shepherd Center ,Restorative Technologies Laboratory ,National Institute On Independent Living ,Neither The Company ,Rehabilitation Research ,National Institutes Of Health ,Physiology Biophysics At University Of Washington ,Engineering Research Center ,University Of Washington ,Company Enquiries ,Dave Marver ,Chief Executive Officer ,Edelle Field Fote ,Spinal Cord Injury Research ,Shepherd Center ,Rehabilitation Medicine ,Emory University School ,Associate Professor ,Electrical Computer Engineering ,Breakthrough Device Designations ,High Tech Campus ,National Institutes ,National Institute ,Independent Living ,Spinal Cord Injury Rehabilitation ,Physiology Biophysics ,Allen Distinguished Investigator ,Christopher Dana Reeve International Consortium ,Spinal Cord ,Research Center ,Investor Enquiries ,Wonward ,Nnounces ,Completion ,Enrollment ,Gift ,Pivotal ,Trial ,Therapy ,Espinal ,Ford ,Injury ,